Astal Laboratories Adjusts Evaluation Amid Strong Sales Growth and Management Efficiency Challenges
Astal Laboratories has recently adjusted its evaluation, reflecting changes in the stock's technical landscape. The company boasts strong financial metrics, including a low Debt to Equity ratio and impressive growth in net sales and operating profit. However, it faces challenges in management efficiency, as indicated by its Return on Equity.
Astal Laboratories, a microcap company in the Trading & Distributors industry, has recently undergone an adjustment in its evaluation. This revision reflects a shift in the technical landscape surrounding the stock, with indicators showing a transition from a bullish to a mildly bullish trend. The company has demonstrated notable financial metrics, including a low Debt to Equity ratio of 0.07 times, which suggests a manageable level of debt relative to equity. Astal Laboratories has reported impressive growth in net sales, achieving an annual growth rate of 138.66%, alongside a significant operating profit increase of 70.72%. The latest quarter's net sales reached Rs 25.33 crore, contributing to a positive trajectory over the past six quarters.
Despite these strengths, the company faces challenges in management efficiency, as indicated by a Return on Equity (ROE) of 7.04%. This figure highlights a lower profitability per unit of shareholders' funds. The stock is currently trading at a premium compared to its peers' average historical valuations, reflecting its market position.
For those interested in further insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
